RxDoctor Payments Data

Arzhang Fallahi, MD

Interventional Cardiology · Stamford, CTNPI 1679734800

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (53.3%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Biotronik Inc. at 45.9% of the total. 2025 is the largest year on record at $6,653, 2.8 times the $2,402 reported in 2019.

$11,791in general payments, 2019–2025

Across 85 payments — averaging $138.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotronik Inc.$5K
  • Edwards Lifesciences$4K
  • Abbott$1K
  • Medtronic$481
  • Inari Medical, Inc.$318
  • Silk Road Medical, Inc.$120
  • plus $110 from 5 others

What the payments were for

  • Consulting fees$5304%
  • Speaking & faculty fees$1,50013%
  • Travel & lodging$6,28953%
  • Food & beverage$3,47229%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,791 in reported general payments places this provider in the 70th percentile of 73 interventional cardiology providers in Connecticut.

See all interventional cardiology providers in Connecticut

Medicare billing

Part B allowed, 2024
$164,851
Medicare patients
520
Services billed
1,438

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor25$20,322
EliquisApixaban11$11,666
XareltoRivaroxaban12$8,014
Atorvastatin Calcium100$874
Rosuvastatin Calcium51$588
ClopidogrelClopidogrel Bisulfate42$409
Metoprolol Succinate42$391
Carvedilol37$231
Omeprazole12$204
Amlodipine Besylate18$178
Losartan Potassium18$168
Isosorbide Mononitrate ErIsosorbide Mononitrate15$103
Furosemide20$81
Lisinopril31$71

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Stamford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →